SOD1 mutants have been largely demonstrated to maintain their enzymatic activity, suggesting that the role of mSOD1 in ALS is characterized by a gain-of-toxic function, rather than by a loss of function feature [116,117]. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.